Levetiracetam ER
NDC 71205-880, Levetiracetam, tablet, film coated, extended release, from Proficient Rx LP.
- Product NDC
- 71205-880
- Status
- Listed
- Labeler
- Proficient Rx LP
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205130
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71205-880 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM500 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71205-880-00 | 71205088000 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-880-00) |
| 71205-880-11 | 71205088011 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-880-11) |
| 71205-880-30 | 71205088030 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-880-30) |
| 71205-880-55 | 71205088055 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-880-55) |
| 71205-880-60 | 71205088060 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-880-60) |
| 71205-880-64 | 71205088064 | 240 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-880-64) |
| 71205-880-72 | 71205088072 | 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-880-72) |
| 71205-880-78 | 71205088078 | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-880-78) |
| 71205-880-90 | 71205088090 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71205-880-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/57b9dccb-6ee6-4e89-ab26-4c478e2df2b5
Use it
Look up 71205-880 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71205-880 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71205-880. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.